A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Typhoon Dolphin brings strong winds, minor injuries to northern Taiwan
08/08/2026 08:46 PM - Society
Typhoon Dolphin disrupts air and sea transportation
08/08/2026 08:38 PM - Society
Typhoon Dolphin prompts precautionary closure of Danjiang Bridge lanes
08/08/2026 06:52 PM - Business
CPC to keep domestic gasoline, diesel prices unchanged next week
08/08/2026 05:50 PM - Society
Possibility of land warning for Typhoon Dolphin downgraded: CWA
08/08/2026 04:20 PM